| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4344352 | Neuroscience Letters | 2012 | 5 Pages |
Abstract
⺠HSV-based vectors are particularly suitable for delivering genes to the DRG. ⺠Preclinical studies in pain and for treatment of polyneuropathy are reviewed. ⺠Results of the first phase 1 clinical trial support this approach.
Keywords
Related Topics
Life Sciences
Neuroscience
Neuroscience (General)
Authors
Darren Wolfe, Marina Mata, David J. Fink,